---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-25-000089"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:27:07.241371+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ANI Pharmaceuticals files 8-K for investor presentation at conferences; no financial details provided

## Summary
- CEO Nikhil Lalwani to present at H.C. Wainwright and Morgan Stanley healthcare conferences on Sep 8-9, 2025.
- Updated investor presentation furnished as Exhibit 99.1 but content not available in extracted filing.
- No specific financial results, guidance, or material operational updates disclosed in the filing body.
- Filing under Items 2.02 and 7.01 is routine and does not contain new performance data.

## SEC filing metadata
- accession: 0001023024-25-000089
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000089/0001023024-25-000089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000089/ani-20250908.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-25-000089
- JSON: https://secwatch.observer/filing/0001023024-25-000089.json
- Plain text: https://secwatch.observer/filing/0001023024-25-000089.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.